Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of COVID-19 Recovery

Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, View ORCID ProfileAbhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry, Guobao Wang
doi: https://doi.org/10.1101/2023.03.26.23287673
Yiran Wang
1Department of Radiology, University of California Davis Medical Center
2Department of Biomedical Engineering, University of California, Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yrdwang{at}ucdavis.edu
Lorenzo Nardo
1Department of Radiology, University of California Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin A. Spencer
2Department of Biomedical Engineering, University of California, Davis
1Department of Radiology, University of California Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasser G. Abdelhafez
1Department of Radiology, University of California Davis Medical Center
3Nuclear Medicine Unit, South Egypt Cancer Institute, Assiut University, Egypt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth J. Li
2Department of Biomedical Engineering, University of California, Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Negar Omidvari
2Department of Biomedical Engineering, University of California, Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abhijit J. Chaudhari
1Department of Radiology, University of California Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abhijit J. Chaudhari
Ramsey D. Badawi
1Department of Radiology, University of California Davis Medical Center
2Department of Biomedical Engineering, University of California, Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terry Jones
1Department of Radiology, University of California Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon R. Cherry
2Department of Biomedical Engineering, University of California, Davis
1Department of Radiology, University of California Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guobao Wang
1Department of Radiology, University of California Davis Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Conventional whole-body 18F-FDG PET imaging provides a semi-quantitative evaluation of overall glucose metabolism without gaining insight into the specific transport and metabolic steps. Here we demonstrate the ability of total-body multiparametric 18F-FDG PET to quantitatively evaluate glucose metabolism using macroparametric quantification and assess specific glucose delivery and phosphorylation processes using microparametric quantification for studying recovery from coronavirus disease 2019 (COVID-19).

Methods The study included thirteen healthy subjects and twelve recovering COVID-19 subjects within eight weeks of confirmed diagnosis. Each subject had a dynamic 18F-FDG scan on the uEXPLORER total-body PET/CT system for one hour. Semiquantitative standardized uptake value (SUV) and SUV ratio relative to blood (SUVR) were calculated for regions of interest (ROIs) in different organs to measure glucose utilization. Tracer kinetic modeling was performed to quantify microparametric rate constants K1 and k3 that characterize 18F-FDG blood-to-tissue delivery and intracellular phosphorylation, respectively, and a macroparameter Ki that represents 18F-FDG net influx rate. Statistical tests were performed to examine differences between the healthy controls and recovering COVID-19 subjects. Impact of COVID-19 vaccination was investigated. We further generated parametric images to confirm the ROI-based analysis.

Results We detected no significant difference in lung SUV but significantly higher lung SUVR and Ki in the recovering COVID-19 subjects, indicating an improved sensitivity of kinetic quantification for detecting the difference in glucose metabolism. A significant difference was also observed in the lungs with the phosphorylation rate k3, but not with the delivery rate K1, which suggests it is glucose phosphorylation, not glucose delivery, that drives the observed difference of glucose metabolism in the lungs. Meanwhile, there was no or little difference in bone marrow metabolism measured with SUV, SUVR and Ki, but a significant increase in bone-marrow 18F-FDG delivery rate K1 in the COVID-19 group (p < 0.05), revealing a difference of glucose delivery in this immune-related organ. The observed differences were lower or similar in vaccinated COVID-19 subjects as compared to unvaccinated ones. The organ ROI-based findings were further supported by parametric images.

Conclusions Higher lung glucose metabolism and bone-marrow glucose delivery were observed with total-body multiparametric 18F-FDG PET in recovering COVID-19 subjects as compared to healthy subjects, which suggests continued inflammation due to COVID-19 during the early stages of recovery. Total-body multiparametric PET of 18F-FDG delivery and metabolism can provide a more sensitive tool and more insights than conventional static whole-body 18F-FDG imaging to evaluate metabolic changes in systemic diseases such as COVID-19.

Competing Interest Statement

This research is supported in part by the National Institutes of Health (NIH) Grants R01 CA206187, R01 DK124803, and R01 AR076088. University of California, Davis has a research agreement and revenue sharing agreement with United Imaging Healthcare. No other potential conflicts of interest relevant to this article exist. We gratefully acknowledge the technologists and staff, particularly Lynda E. Painting, of the EXPLORER Molecular Imaging Center (EMIC), for their assistance in patient consent and data acquisition.

Funding Statement

This research is supported in part by the National Institutes of Health (NIH) Grants R01 CA206187, R01 DK124803, and R01 AR076088. University of California, Davis has a research agreement and revenue sharing agreement with United Imaging Healthcare.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of University of California, Davis gave ethical approval for this work. The IRB number is 1697954. The ClinicalTrials.gov Identifier is NCT04841707.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Disclaimer: None.

  • Financial support: NIH grants R01 CA206187, R01 DK124803 and R01 AR076088.

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 30, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of COVID-19 Recovery
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of COVID-19 Recovery
Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry, Guobao Wang
medRxiv 2023.03.26.23287673; doi: https://doi.org/10.1101/2023.03.26.23287673
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of COVID-19 Recovery
Yiran Wang, Lorenzo Nardo, Benjamin A. Spencer, Yasser G. Abdelhafez, Elizabeth J. Li, Negar Omidvari, Abhijit J. Chaudhari, Ramsey D. Badawi, Terry Jones, Simon R. Cherry, Guobao Wang
medRxiv 2023.03.26.23287673; doi: https://doi.org/10.1101/2023.03.26.23287673

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Radiology and Imaging
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)